Physician profile
John D Wrightson
NPI 1861462798
$24,881.42
in general payments reported to CMS, 2019-2025
48 companies · $3,208 in 2025
The $3,208 reported for 2025 was more than what 91% of Pain Medicine (Physical Medicine & Rehabilitation) providers received nationally (typical 2025 total: $400).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $3,387 · 2020: $2,555 · 2021: $3,460 · 2022: $3,942 · 2023: $4,425 · 2024: $3,905 · 2025: $3,208.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $10K · Travel and Lodging: $1,236.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $10,301.81 |
| Travel and Lodging | $1,236.03 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbott Laboratories | $11,415.59 | 2019-2025 | Proclaim, Eterna, Axium |
| Boston Scientific Corporation | $1,681.06 | 2019-2025 | Intracept, Wavewriter Alpha Prime 16, General - Pain Management |
| Collegium Pharmaceutical, INC. | $1,556.57 | 2019-2025 | Xtampza, Belbuca, Nucynta |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $1,134.60 | 2019-2025 | Relistor |
| Abbvie INC. | $1,034.80 | 2021-2025 | Ubrelvy, Qulipta |
| Tersera Therapeutics LLC | $963.35 | 2019-2025 | Prialt |
| Teva Pharmaceuticals USA, INC. | $456.93 | 2020-2025 | Ajovy, Austedo, Austedo Xr |
| Surgentec | $449.51 | 2023 | Tilink |
| Grt US Holding, INC. | $449.19 | 2020-2022 | |
| Nevro Corp. | $432.33 | 2021-2024 | Senza |
| Biodelivery Sciences International, INC. | $391.14 | 2019-2021 | |
| Scilex Pharmaceuticals INC. | $386.42 | 2019-2024 | Ztlido |
| Virtus Pharmaceuticals LLC | $372.43 | 2021-2025 | Levorphanol Tartrate |
| Foundation Fusion Solutions, LLC | $359.52 | 2021-2022 | |
| Zyla Life Sciences, INC. | $295.41 | 2019-2020 |
Show all 48 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Protega Pharmaceutials INC | $288.02 | 2022-2024 | Roxybond |
| Lilly USA, LLC | $277.64 | 2020-2025 | Emgality, Reyvow, Zepbound |
| Pacira Therapeutics, INC. | $276.02 | 2019-2020 | |
| Daiichi Sankyo INC. | $273.86 | 2019 | |
| Axonics, INC. | $260.28 | 2021-2023 | Axonics |
| Medtronic, INC. | $256.80 | 2023-2025 | Synchromedii, Vanta Adaptivestim, Osteocool Rf Ablation System |
| Sentynl Therapeutics, INC. | $237.44 | 2019-2020 | |
| Valinor Pharma, LLC | $219.51 | 2023-2024 | Movantik |
| Arbor Pharmaceuticals, INC. | $175.61 | 2020-2022 | |
| Relievant Medsystems, INC. | $146.98 | 2023 | Intracept |
| Redhill Biopharma INC. | $123.24 | 2020-2022 | |
| Inspire Medical Systems, INC. | $113.41 | 2025 | Inspire |
| Pfizer INC. | $112.90 | 2019-2021 | |
| Si-Bone, INC. | $89.22 | 2020-2023 | |
| Bioventus LLC | $70.44 | 2019-2023 | Stimrouter Implantable Kit |
| Appliedvr INC | $63.24 | 2024-2025 | Relievrx |
| Interventional Pain Technologies INC. | $61.05 | 2022 | |
| Mdd US Operations, LLC | $51.65 | 2019-2020 | |
| Astrazeneca Pharmaceuticals Lp | $50.31 | 2020 | |
| Flowonix Medical Incorporated | $46.13 | 2019-2020 | |
| Vertiflex, INC. | $42.58 | 2019 | |
| Averitas Pharma INC. | $41.81 | 2025 | Qutenza |
| Idorsia Pharmaceuticals US INC | $39.80 | 2022-2023 | Quviviq |
| Kowa Pharmaceuticals America, INC. | $28.42 | 2023 | Seglentis |
| Mindray Ds USA, INC. | $26.99 | 2024 | Te X, Te7 Max |
| Allergan, INC. | $18.59 | 2019 | |
| Pacira Pharmaceuticals Incorporated | $18.44 | 2024 | Zilretta, Iovera |
| Spr Therapeutics, INC | $18.12 | 2023 | Sprint Pns System |
| Ibsa Pharma INC. | $17.00 | 2024 | Tirosint, Licart |
| Nalu Medical, INC. | $15.75 | 2025 | Nalu Neurostimulation System |
| Tonix Medicines, INC. | $14.07 | 2025 | Tonmya |
| Assertio Therapeutics, INC. | $13.95 | 2019 | |
| Alfasigma USA, INC. | $13.30 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw John Wrightson listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.